Quantitative structure-activity relationships for cellular uptake of surface-modified nanoparticles

Combinatorial Chemistry and High Throughput Screening

Volumn 18, Issue 4, 2015, Pages 365-375

  Liu, Rong ^a   Rallo, Robert ^b   Bilal, Muhammad ^a   Cohen, Yoram ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^c Engineering IV   (United States)

Author keywords

Nano QSAR; Nanomaterial; Nanoparticle uptake; QSAR; Surface modification

Indexed keywords

IRON OXIDE; METAL NANOPARTICLE; FERRIC ION; FERRIC OXIDE; NANOPARTICLE;

ACCURACY; ARTICLE; BOOTSTRAPPING; CELL TRANSPORT; ENTHALPY; EPSILON SUPPORT VECTOR REGRESSION; LINEAR REGRESSION ANALYSIS; LINEAR SYSTEM; MOLECULAR SIZE; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SUPPORT VECTOR MACHINE; SURFACE CHARGE; ZETA POTENTIAL; CHEMISTRY; METABOLISM; SURFACE PROPERTY;

FERRIC COMPOUNDS; NANOPARTICLES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES;

EID: 84931271982     PISSN: 13862073     EISSN: 18755402     Source Type: Journal    
DOI: 10.2174/1386207318666150306105525     Document Type: Article

References (100)

1. Murty, B. S.; Shankar, P.; Raj, B.; Rath, B. B.; Murday, J. Applications of Nanomaterials. In Textbook of Nanoscience and Nanotechnology; Springer Berlin Heidelberg, 2013.
2. Guo, Z.; Tan, L. Fundamentals and Applications of Nanomaterials; Artech House: Boston, 2009.
3. Davis, M. E.; Chen, Z. G.; Shin, D. M. Nanoparticle Therapeutics: An Emerging Treatment Modality for Cancer. Nat. Rev. Drug Discov., 2008, 7, 771-782.
4. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy. Nat. Nanotechnol., 2007, 2, 751-760.
5. Mai, W. X.; Meng, H. Mesoporous Silica Nanoparticles: A Multifunctional Nano Therapeutic System. Integr. Biol., 2013, 5, 19-28.
6. Nel, A.; Xia, T.; Mädler, L.; Li, N. Toxic Potential of Materials at the Nanolevel. Science, 2006, 311, 622-627.
7. Xia, T.; Malasarn, D.; Lin, S.; Ji, Z.; Zhang, H.; Miller, R. J.; Keller, A. A.; Nisbet, R. M.; Harthorn, B. H.; Godwin, H. A.; et al. Implementation of a Multidisciplinary Approach to Solve Complex Nano EHS Problems by the UC Center for the Environmental Implications of Nanotechnology. Small, 2013, 9, 1428-1443.
8. Handy, R. D.; Shaw, B. J. Toxic Effects of Nanoparticles and Nanomaterials: Implications for Public Health, Risk Assessment and the Public Perception of Nanotechnology. Health. Risk Soc., 2007, 9, 125-144.
9. Helland, A.; Scheringer, M.; Siegrist, M.; Kastenholz, H. G.; Wiek, A.; Scholz, R. W. Risk Assessment of Engineered Nanomaterials: A Survey of Industrial Approaches. Environ. Sci. Technol., 2007, 42, 640-646.
10. Hristozov, D. R.; Gottardo, S.; Critto, A.; Marcomini, A. Risk Assessment of Engineered Nanomaterials: A Review of Available Data and Approaches from a Regulatory Perspective. Nanotoxicology, 2012, 6, 880-898.
11. Grieger, K. D.; Linkov, I.; Hansen, S. F.; Baun, A. Environmental Risk Analysis for Nanomaterials: Review and Evaluation of Frameworks. Nanotoxicology, 2011, 6, 196-212.
12. Cheng, L.-C.; Jiang, X.; Wang, J.; Chen, C.; Liu, R.-S. Nano-Bio Effects: Interaction of Nanomaterials with Cells. Nanoscale, 2013, 5, 3547-3569.
13. Sharifi, S.; Behzadi, S.; Laurent, S.; Laird Forrest, M.; Stroeve, P.; Mahmoudi, M. Toxicity of Nanomaterials. Chem. Soc. Rev., 2012, 41, 2323-2343.
14. Pelley, J. L.; Daar, A. S.; Saner, M. A. State of Academic Knowledge on Toxicity and Biological Fate of Quantum Dots. Toxicol. Sci., 2009, 112, 276-296.
15. King-Heiden, T. C.; Wiecinski, P. N.; Mangham, A. N.; Metz, K. M.; Nesbit, D.; Pedersen, J. A.; Hamers, R. J.; Heideman, W.; Peterson, R. E. Quantum Dot Nanotoxicity Assessment Using the Zebrafish Embryo. Environ. Sci. Technol., 2009, 43, 1605-1611.
16. Jiang, W.; Kim, B. Y. S.; Rutka, J. T.; Chan, W. C. W. Nanoparticle-Mediated Cellular Response Is Size-Dependent. Nature nanotechnology, 2008, 3, 145-150.
17. Ehrenberg, M. S.; Friedman, A. E.; Finkelstein, J. N.; Oberd?ster, G.; McGrath, J. L. The Influence of Protein Adsorption on Nanoparticle Association with Cultured Endothelial Cells. Biomaterials, 2009, 30, 603-610.
18. Brunner, T. J.; Wick, P.; Manser, P.; Spohn, P.; Grass, R. N.; Limbach, L. K.; Bruinink, A.; Stark, W. J. In Vitro Cytotoxicity of Oxide Nanoparticles: Comparison to Asbestos, Silica, and the Effect of Particle Solubility. Environ. Sci. Technol., 2006, 40, 4374-4381.
19. Zhu, X.; Zhu, L.; Chen, Y.; Tian, S. Acute Toxicities of Six Manufactured Nanomaterial Suspensions to Daphnia Magna. J. Nanoparticle Res., 2009, 11, 67-75.
20. Hu, X.; Cook, S.; Wang, P.; Hwang, H.-M. In Vitro Evaluation of Cytotoxicity of Engineered Metal Oxide Nanoparticles. Sci. Total Environ., 2009, 407, 3070-3072.
21. Stoeger, T.; Takenaka, S.; Frankenberger, B.; Ritter, B.; Karg, E.; Maier, K.; Schulz, H.; Schmid, O. Deducing in Vivo Toxicity of Combustion-Derived Nanoparticles from a Cell-Free Oxidative Potency Assay and Metabolic Activation of Organic Compounds. Environ. Health Perspect., 2009, 117, 54-60.
22. Braydich-Stolle, L.; Schaeublin, N.; Murdock, R.; Jiang, J.; Biswas, P.; Schlager, J.; Hussain, S. Crystal Structure Mediates Mode of Cell Death in TiO2 Nanotoxicity. J. Nanoparticle Res., 2009, 11, 1361-1374.
23. Yu, Y.; Zhang, Q.; Mu, Q.; Zhang, B.; Yan, B. Exploring the Immunotoxicity of Carbon Nanotubes. Nanoscale Res. Lett., 2008, 3, 271-277.
24. Kahru, A.; Dubourguier, H.-C. From Ecotoxicology to Nanoecotoxicology. Toxicology, 2010, 269, 105-119.
25. Ray, P. C.; Yu, H.; Fu, P. P. Toxicity and Environmental Risks of Nanomaterials: Challenges and Future Needs. J. Environ. Sci. Health. C. Environ. Carcinog. Ecotoxicol. Rev., 2009, 27, 1-35.
26. Xiao-feng, P.; Bo, D.; Qiang, Z. Synthesis of Magnetic Nanobiomaterials and Its Biological Effects. J. Nanosci. Nanotechnol., 2009, 9, 1369-1373.
27. Zhang, H.; Ji, Z.; Xia, T.; Meng, H.; Low-Kam, C.; Liu, R.; Pokhrel, S.; Lin, S.; Wang, X.; Liao, Y.-P.; et al. Use of Metal Oxide Nanoparticle Band Gap to Develop a Predictive Paradigm for Oxidative Stress and Acute Pulmonary Inflammation. ACS Nano, 2012, 6, 4349-4368.
28. Wang, X.; Xia, T.; Ntim, S. A.; Ji, Z.; Lin, S.; Meng, H.; Chung, C.-H.; George, S.; Zhang, H.; Wang, M.; et al. Dispersal State of Multiwalled Carbon Nanotubes Elicits Profibrogenic Cellular Responses That Correlate with Fibrogenesis Biomarkers and Fibrosis in the Murine Lung. ACS Nano, 2011, 5, 9772-9787.
29. Asharani, P. V; Lianwu, Y.; Gong, Z.; Valiyaveettil, S. Comparison of the Toxicity of Silver, Gold and Platinum Nanoparticles in Developing Zebrafish Embryos. Nanotoxicology, 2011, 5, 43-54.
30. Hardman, R. A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors. Environ. Health Perspect., 2006, 114, 165-172.
31. Ahmad, F.; Pandey, A.; Herzog, A.; Rose, J.; Gerba, C.; Hashsham, S. Environmental Applications and Potential Health Implications of Quantum Dots. J. Nanoparticle Res., 2012, 14, 1-24.
32. Cho, S. J.; Maysinger, D.; Jain, M.; Röder, B.; Hackbarth, S.; Winnik, F. M. Long-Term Exposure to CdTe Quantum Dots Causes Functional Impairments in Live Cells. Langmuir, 2007, 23, 1974-1980.
33. Cattaneo, A. G.; Gornati, R.; Sabbioni, E.; Chiriva-Internati, M.; Cobos, E.; Jenkins, M. R.; Bernardini, G. Nanotechnology and Human Health: Risks and Benefits. J. Appl. Toxicol., 2010, 30, 730-744.
34. Tinkle, S. S. Maximizing Safe Design of Engineered Nanomaterials: The NIH and NIEHS Research Perspective. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2010, 2, 88-98.
35. Cohen, Y.; Rallo, R.; Liu, R.; Liu, H. H. In Silico Analysis of Nanomaterials Hazard and Risk. Acc. Chem. Res., 2012, 46, 802-812.
36. Winkler, D. A.; Burden, F. R.; Yan, B.; Weissleder, R.; Tassa, C.; Shaw, S.; Epa, V. C. Modelling and Predicting the Biological Effects of Nanomaterials. SAR QSAR Environ. Res., 2014, 25, 161-172.
37. Winkler, D. A.; Mombelli, E.; Pietroiusti, A.; Tran, L.; Worth, A.; Fadeel, B.; McCall, M. J. Applying Quantitative Structure-activity Relationship Approaches to Nanotoxicology: Current Status and Future Potential. Toxicology, 2013, 313, 15-23.
38. Puzyn, T.; Leszczynska, D.; Leszczynski, J. Toward the Development of "Nano-QSARs": Advances and Challenges. Small, 2009, 5, 2494-2509.
39. Puzyn, T.; Rasulev, B.; Gajewicz, A.; Hu, X.; Dasari, T. P.; Michalkova, A.; Hwang, H.-M.; Toropov, A.; Leszczynska, D.; Leszczynski, J. Using Nano-QSAR to Predict the Cytotoxicity of Metal Oxide Nanoparticles. Nature nanotechnology, 2011, 6, 175-178.
40. Shaw, S. Y.; Westly, E. C.; Pittet, M. J.; Subramanian, A.; Schreiber, S. L.; Weissleder, R. Perturbational Profiling of Nanomaterial Biologic Activity. PNAS, 2008, 105, 7387-7392.
41. Poater, A.; Gallegos Saliner, A.; Solá, M.; Cavallo, L.; Worth, A. P. Computational Methods to Predict the Reactivity of Nanoparticles through Structure-Property Relationships. Expert Opin. Drug Deliv., 2010, 7, 295-305.
42. Gajewicz, A.; Schaeublin, N.; Rasulev, B.; Hussain, S.; Leszczynska, D.; Puzyn, T.; Leszczynski, J. Towards Understanding Mechanisms Governing Cytotoxicity of Metal Oxides Nanoparticles: Hints from Nano-QSAR Studies. Nanotoxicology, 2014, 1-13.
43. Yang, Y.; Lin, T.; Weng, X. L.; Darr, J. A.; Wang, X. Z. Data Flow Modeling, Data Mining and QSAR in High-Throughput Discovery of Functional Nanomaterials. Comput. Chem. Eng., 2011, 35, 671-678.
44. Gajewicz, A.; Rasulev, B.; Dinadayalane, T. C.; Urbaszek, P.; Puzyn, T.; Leszczynska, D.; Leszczynski, J. Advancing Risk Assessment of Engineered Nanomaterials: Application of Computational Approaches. Adv. Drug Deliv. Rev., 2012, 64, 1663-1693.
45. Sayes, C.; Ivanov, I. Comparative Study of Predictive Computational Models for Nanoparticle-Induced Cytotoxicity. Risk Anal., 2010, 30, 1723-1734.
46. Liu, R.; Rallo, R.; Weissleder, R.; Tassa, C.; Shaw, S.; Cohen, Y. Nano-SAR Development for Bioactivity of Nanoparticles with Considerations of Decision Boundaries. Small, 2013, 9, 1842-1852.
47. Liu, R.; Rallo, R.; George, S.; Ji, Z.; Nair, S.; Nel, A. E.; Cohen, Y. Classification NanoSAR Development for Cytotoxicity of Metal Oxide Nanoparticles. Small, 2011, 7, 1118-1126.
48. Liu, R.; Zhang, H. Y.; Ji, Z. X.; Rallo, R.; Xia, T.; Chang, C. H.; Nel, A.; Cohen, Y. Development of Structure-Activity Relationship for Metal Oxide Nanoparticles. Nanoscale, 2013, 5, 5644-5653.
49. Shao, C.-Y.; Chen, S.-Z.; Su, B.-H.; Tseng, Y. J.; Esposito, E. X.; Hopfinger, A. J. Dependence of QSAR Models on the Selection of Trial Descriptor Sets: A Demonstration Using Nanotoxicity Endpoints of Decorated Nanotubes. J. Chem. Inf. Model., 2013, 53, 142-158.
50. Fourches, D.; Pu, D.; Tassa, C.; Weissleder, R.; Shaw, S. Y.; Mumper, R. J.; Tropsha, A. Quantitative Nanostructure-Activity Relationship Modeling. ACS Nano, 2010, 4, 5703-5712.
51. Ghorbanzadeh, M.; Fatemi, M. H.; Karimpour, M. Modeling the Cellular Uptake of Magnetofluorescent Nanoparticles in Pancreatic Cancer Cells: A Quantitative Structure Activity Relationship Study. Ind. Eng. Chem. Res., 2012, 51, 10712-10718.
52. Epa, V. C.; Burden, F. R.; Tassa, C.; Weissleder, R.; Shaw, S.; Winkler, D. A. Modeling Biological Activities of Nanoparticles. Nano Lett., 2012, 12, 5808-5812.
53. Toropov, A. A.; Toropova, A. P.; Puzyn, T.; Benfenati, E.; Gini, G.; Leszczynska, D.; Leszczynski, J. QSAR as a Random Event: Modeling of Nanoparticles Uptake in PaCa2 Cancer Cells. Chemosphere, 2013, 92, 31-37.
54. Kar, S.; Gajewicz, A.; Puzyn, T.; Roy, K. Nano-Quantitative Structure-Activity Relationship Modeling Using Easily Computable and Interpretable Descriptors for Uptake of Magnetofluorescent Engineered Nanoparticles in Pancreatic Cancer Cells. Toxicol. Vitr., 2014, 28, 600-606.
55. Singh, K. P.; Gupta, S. Nano-QSAR Modeling for Predicting Biological Activity of Diverse Nanomaterials. RSC Adv., 2014, 4, 13215-13230.
56. Chau, Y. T.; Yap, C. W. Quantitative Nanostructure-Activity Relationship Modelling of Nanoparticles. RSC Adv., 2012, 2, 8489-8496.
57. Walkey, C. D.; Olsen, J. B.; Song, F.; Liu, R.; Guo, H.; Olsen, W.; Cohen, Y.; Emili, A.; Chan, W. C. W. Protein Corona Fingerprinting Predicts the Cell Association of Gold Nanoparticles. ACS Nano, 2014, 8, 2439-2455.
58. Weissleder, R.; Kelly, K.; Sun, E. Y.; Shtatland, T.; Josephson, L. Cell-Specific Targeting of Nanoparticles by Multivalent Attachment of Small Molecules. Nat. Biotechnol., 2005, 23, 1418-1423.
59. Nyström, A. M.; Fadeel, B. Safety Assessment of Nanomaterials: Implications for Nanomedicine. Journal of Controlled Release, 2012, 161, 403-408.
60. Guidance Document on the Validation of (Quantitative) Structure-Activity Relationship [(Q)SAR] Models; Paris, 2007.
61. Fahrmeir, L.; Kneib, T.; Lang, S.; Marx, B. Regression: Models, Methods and Applications; Springer: New York, 2013.
62. Domingos, P. The Role of Occam's Razor in Knowledge Discovery. Data Min. Knowl. Discov., 1999, 3, 409-425.
63. Puzyn, T.; Leszczynski, J.; Cronin, M. T. Recent Advances in QSAR Studies: Methods and Applications; Springer: New York, 2010.
64. Braga-Neto, U. M.; Dougherty, E. R. Is Cross-Validation Valid for Small-Sample Microarray Classification? Bioinformatics, 2004, 20, 374-380.
65. Efron, B. Estimating the Error Rate of a Prediction Rule: Improvement on Cross-Validation. J. Am. Stat. Assoc., 1983, 78, 316-331.
66. Bishop, C. M. Pattern Recognition and Machine Learning; Springer: New York, 2006.
67. Han, J.; Kamber, M.; Pei, J. Data Mining: Concepts and Techniques; 3rd ed.; Morgan Kaufmann: Waltham, 2011.
68. Larry Wasserman. All of Statistics: A Concise Course in Statistical Inference; Springer: New York, 2004.
69. Chang, C.-C.; Lin, C.-J. LIBSVM: A Library for Support Vector Machines. ACM Trans. Intell. Syst. Technol., 2011, 2, 27.
70. Cristianini, N.; Shawe-Taylor, J. An Introduction to Support Vector Machines: And Other Kernel-Based Learning Methods; Cambridge University Press: New York, NY, USA, 2000.
71. Hsu, C.-W.; Chang, C.-C.; Lin, C.-J.; others. A practical guide to support vector classification. http://www.csie.ntu.edu.tw/~cjlin/papers/guide/guide.pdf.
72. Vapnik, V. N. Statistical Learning Theory; Wiley-Interscience: New York, 1998.
73. Guyon, I.; Elisseeff, A. An Introduction to Variable and Feature Selection. J. Mach. Learn. Res., 2003, 3, 1157-1182.
74. Computational Methods of Feature Selection; Liu, H.; Motoda, H., Eds.; Chapman and Hall/CRC: New York, 2008.
75. Pudil, P.; Novovičová, J.; Kittler, J. Floating Search Methods in Feature Selection. Pattern Recognit. Lett., 1994, 15, 1119-1125.
76. Tropsha, A. Best Practices for QSAR Model Development, Validation, and Exploitation. Molecular Informatics, 2010, 29, 476-488.
77. Liu, R.; Rallo, R.; Cohen, Y. Quantitative Structure-Activity-Relationships for Cellular Uptake of Nanoparticles. In: IEEE International Conference on Nanotechnology, 2013; pp. 154-157.
78. Netzeva, T. I.; Worth, A.; Aldenberg, T.; Benigni, R.; Cronin, M. T. D.; Gramatica, P.; Jaworska, J. S.; Kahn, S.; Klopman, G.; Marchant, C. A.; et al. Current Status of Methods for Defining the Applicability Domain of (quantitative) Structure-Activity Relationships. Altern. to Lab. Anim., 2005, 33, 155-173.
79. Jaworska, J.; Nikolova-Jeliazkova, N.; Aldenberg, T. QSAR Applicabilty Domain Estimation by Projection of the Training Set Descriptor Space: A Review. Altern. Lab. Anim., 2005, 33, 445-459.
80. Fechner, N.; Jahn, A.; Hinselmann, G.; Zell, A. Estimation of the Applicability Domain of Kernel-Based Machine Learning Models for Virtual Screening. J. Cheminform., 2010, 2, 2.
81. Chemical Computing Group Inc. Molecular Operating Environment (MOE), 2008.
82. Cherkassky, V.; Ma, Y. Practical Selection of SVM Parameters and Noise Estimation for SVM Regression. Neural Networks, 2004, 17, 113-126.
83. Cramer R.D., Bunce J.D., P. D. E. Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional. Quant. Struct. Relatsh., 1988, 25, 18-25.
84. Liu, H.; Yu, L. Toward Integrating Feature Selection Algorithms for Classification and Clustering. IEEE Trans. Knowl. Data Eng., 2005, 17, 491-502.
85. Liu, R.; Shi, Y. Spatial Distance Join Based Feature Selection. Eng. Appl. Artif. Intell.
86. Rücker, C.; Rücker, G.; Meringer, M. Y-Randomization and Its Variants in QSPR/QSAR. J. Chem. Inf. Model., 2007, 47, 2345-2357.
87. Svetnik, V.; Liaw, A.; Tong, C.; Culberson, J. C.; Sheridan, R. P.; Feuston, B. P. Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling. J. Chem. Inf. Comput. Sci., 2003, 43, 1947-1958.
88. Eriksson, L.; Jaworska, J.; Worth, A. P.; Cronin, M. T. D.; McDowell, R. M.; Gramatica, P. Methods for Reliability and Uncertainty Assessment and for Applicability Evaluations of Classification-and Regression-Based QSARs. Environ. Health Perspect., 2003, 111, 1361-1375.
89. Liu, R.; Lin, S.; Rallo, R.; Zhao, Y.; Damoiseaux, R.; Xia, T.; Lin, S.; Nel, A.; Cohen, Y. Automated Phenotype Recognition for Zebrafish Embryo Based in Vivo High Throughput Toxicity Screening of Engineered Nano-Materials. PLoS One, 2012, 7, e35014.
90. Mattera, D.; Haykin, S. Support Vector Machines for Dynamic Reconstruction of a Chaotic System. In Advances in Kernel Methods: Support Vector Learning; Schölkopf, B.; Burges, C. J. C.; Smola, A. J., Eds.; MIT Press: Cambridge, MA, 1999; pp. 209-241.
91. Labute, P. A Widely Applicable Set of Descriptors. J. Mol. Graph. Model., 2000, 18, 464-477.
92. Todeschini, R.; Consonni, V. Molecular Descriptors for Chemoinformatics; 2nd ed.; WILEY-VCH: New York, 2009.
93. MOE. QuaSAR-Descriptor http://www.chemcomp.com/journal/descr.htm.
94. Voigt, J.; Christensen, J.; Shastri, V. P. Differential Uptake of Nanoparticles by Endothelial Cells through Polyelectrolytes with Affinity for Caveolae. PNAS, 2014, 111, 2942-2947.
95. Nam, H. Y.; Kwon, S. M.; Chung, H.; Lee, S. Y.; Kwon, S. H.; Jeon, H.; Kim, Y.; Park, J. H.; Kim, J.; Her, S.; et al. Cellular Uptake Mechanism and Intracellular Fate of Hydrophobically Modified Glycol Chitosan Nanoparticles. J. Control. Release, 2009, 135, 259-267.
96. Varela, J. A.; Bexiga, M. G.; Åberg, C.; Simpson, J. C.; Dawson, K. A. Quantifying Size-Dependent Interactions between Fluorescently Labeled Polystyrene Nanoparticles and Mammalian Cells. Journal of Nanobiotechnology, 2012, 10, 39.
97. Albanese, A.; Chan, W. C. W. Effect of Gold Nanoparticle Aggregation on Cell Uptake and Toxicity. ACS Nano, 2011, 5, 5478-5489.
98. Yang, J. A.; Lohse, S. E.; Murphy, C. J. Tuning Cellular Response to Nanoparticles via Surface Chemistry and Aggregation. Small, 2014, 10, 1642-1651.
99. Amstad, E.; Textor, M.; Reimhult, E. Stabilization and Functionalization of Iron Oxide Nanoparticles for Biomedical Applications. Nanoscale, 2011, 3, 2819-2843.
100. Rivera-Gil, P.; Clift, M. J. D.; Rutishauser, B. R.; Parak, W. J. Methods for Understanding the Interaction between Nanoparticles and Cells. Methods Mol. Biol., 2012, 926, 33-56.